(Total Views: 313)
Posted On: 07/04/2019 12:05:47 PM
Post# of 41

$GRFS News Article - Grifols Announces FDA Approval of Xembify , 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies https://marketwirenews.com/news-releases/grif...43271.html


My Twitter: WhyteStocks